Based on the strong polymeric role of phosphate (PO4-) on the PFS, PO4(3-) was introduced in the ferric sulfate (PFS), and a new type of composite flocculant polymeric phosphate ferric sulfate (PPFS) was developed. The study includes the preparation of PPFS, and erric species distribution in PFSS was investigated by ultraviolet-visible spectrum method, infrared spectrum method and Fe-ferron complexation timed spectrophotometry method. The ultraviolet-visible spectrum showed that the change in the spectral curve of the different pH polymer ferric sulfate flocculants is corresponding to the flocculation morphology. Infrared spectra showed that the -P-O or -P=O vibration exists in the PPFS, certificated the ferric ion in PFS and phosphate caused the reaction, and produced the phosphate ferric polymer; and Fe-ferron complexation timed spectrophotometry showed that the amount of Fe(c) in polymeric phosphate ferric sulfate (PPFS) flocculants was the most in the three species, while the amount of Fe(a) and Fe(b) was small, that is PPFS mainly exists in the form of phosphate ferric polymer.
Download full-text PDF |
Source |
---|
Molecules
January 2025
Institute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko Str. 24, LT-03225 Vilnius, Lithuania.
This research presents a simple procedure for chemically modifying yeast () cells with nickel hexacyanoferrate (NiHCF) and ferric hexacyanoferrate, also known as Prussian blue (PB), to increase the conductivity of the yeast cell wall. Using linear sweep voltammetry, NiHCF-modified yeast and PB-modified yeast (NiHCF/yeast and PB/yeast, respectively) were found to have better cell wall conductivity in [Fe(CN)] and glucose-containing phosphate-buffered solution than unmodified yeast. Spectrophotometric analysis showed that the modification of yeast cells with NiHCF had a less harmful effect on yeast cell viability than the modification of yeast cells with PB.
View Article and Find Full Text PDFEnviron Sci Technol
January 2025
Soil Chemistry Group, Institute of Biogeochemistry and Pollutant Dynamics, CHN, ETH Zürich, 8092 Zürich, Switzerland.
Coastal sediments are a key contributor to oceanic phosphorus (P) removal, impacting P bioavailability and primary productivity. Vivianite, an Fe(II)-phosphate mineral, can be a major P sink in nonsulfidic, reducing coastal sediments. Despite its importance, vivianite formation processes in sediments remain poorly understood.
View Article and Find Full Text PDFWater Res
March 2025
State Environmental Protection Key Laboratory of Source Apportionment and Control of Aquatic Pollution & School of Environmental Studies & State Key Laboratory of Biogeology and Environmental Geology, China University of Geosciences, Wuhan 430074, China.
Understanding the competition for adsorption between arsenate and other common oxyanions at mineral-water interfaces is critical for enhancing arsenate retention in the subsurface environment and mitigating exposure risks. This study investigated the competitive adsorption between arsenate and phosphate on hematite facets using batch experiments, together with in-situ infrared spectroscopy, two-dimensional correlation spectroscopy (2D-COS), and ab initio molecular dynamic (AIMD) simulations. This study's findings revealed that hematite exhibited notable selectivity for arsenate over phosphate in both adsorption capacity and rate, with selectivity significantly influenced by the exposed facets of the hematite and reaction concentrations.
View Article and Find Full Text PDFJ Med Econ
December 2024
Covalence Research Ltd, Harpenden, UK.
Aims: Iron deficiency anemia (IDA) is among the most common extraintestinal sequelae of inflammatory bowel disease (IBD). Intravenous iron is often the preferred treatment in patients with active inflammation with or without active bleeding, iron malabsorption, or intolerance to oral iron. The aim of the present study was to evaluate the cost-utility of ferric derisomaltose (FDI) versus ferric carboyxymaltose (FCM) in patients with IBD and IDA in Norway.
View Article and Find Full Text PDFCureus
November 2024
Acute Medicine, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Although parenteral iron is widely used to treat iron deficiency anemia (IDA), some side effects have been inadequately explored. Hypophosphatemia is becoming a well-documented, yet poorly understood, side effect of parenteral iron infusion, oftentimes causing serious and/or prolonged complications. In this article, we discuss the case of a 33-year-old female with IDA who suffered debilitating physical and mental symptoms of significant recurrent hypophosphatemia following a single standard dose of parenteral iron administration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!